öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÂÀÉê
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º115

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚ¶þÁÙ´²Ñ§Ôº
Ö°³Æ£º½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º²¡ÀíѧÓ벡ÀíÉúÀíѧ
Ñо¿ÁìÓò£º ¢ÙÖ×Áö·Ö×Ó²¡Àíѧ¢ÚÖ×Áö·Ö×Ó°ÐÏòÒ©ÎïÃô¸ÐÈËȺɸÑ¡¢ÛÖ×Áö΢»·¾³ÓëEGFR-TKI»ñµÃÐÔÄÍÒ©»úÖÆ
Ñо¿ÁìÓò£º ¢ÙÖ×Áö·Ö×Ó²¡Àíѧ¢ÚÖ×Áö·Ö×Ó°ÐÏòÒ©ÎïÃô¸ÐÈËȺɸÑ¡¢ÛÖ×Áö΢»·¾³ÓëEGFR-TKI»ñµÃÐÔÄÍÒ©»úÖÆ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºlu.shen1956@aliyun.com


¸öÈ˼òÊö :
ÂÀÉ꣬ÄУ¬1956Äê9ÔÂÉú£¬1982Äê±ÏÒµÓÚÖйúÒ½¿Æ´óѧ£¬1998ÄêÓÚÈÕ±¾Ôý»ÏÒ½¿Æ´óѧ»ñ²©Ê¿Ñ§Î»ºó»Ø¹ú¹¤×÷¡£ÏÖÈδóÁ¬Ò½¿Æ´óѧ¸½ÊôµÚ¶þÒ½Ôº¿ÆÑÐÖÐÐÄÖ÷ÈΣ¬´óÁ¬Ò½¿Æ´óѧ²¡Àíѧ½ÌÊÚ¡¢²©Ê¿Éúµ¼Ê¦¡¢²©Ê¿ºóÁ÷¶¯Õ¾ºÏ×÷Ö¸µ¼½ÌÊÚ£¬Èιú¼Ê²¡Àíѧ»á»áÔ±£¬´óÁ¬Ò½¿Æ´óѧѧ±¨¸±Ö÷±à¡£2001ÄêÈëÑ¡ÁÉÄþÊ¡µÚ¶þÅú°ÙǧÍòÈ˲Ź¤³Ì°ÙÈ˲ã´Î¡£±ÏÒµºóÈýÊ®ÓàÄêÒ»Ö±ÔÚÁÙ´²¡¢½Ìѧ¼°¿ÆѧÑо¿µÚÒ»Ïß¹¤×÷£¬Ã¿Äê³Ðµ£Ñ§Ð£¡¶²¡Àíѧ¡·½Ìѧ¹¤×÷100Óàѧʱ¡£Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðµÈ¿ÎÌâ¶àÏÔø¶à´Î»ñµÃÁÉÄþÊ¡¿Æ¼¼½ø²½¶þµÈ½±¡¢ÈýµÈ½±¡£

¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿¢Ù ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬¾ÞÊÉϸ°û¶Ô·ÇСϸ°û·Î°©±íƤÉú³¤Òò×ÓÊÜÌåÀÒ°±ËἤøÒÖÖƼÁ»ñµÃÐÔÄÍÒ©²úÉúµÄ´Ù½ø×÷ÓÃÑо¿£¬ÏîÄ¿Åú×¼ºÅ£º**£¬2016Äê1ÔÂ-2019Äê12Ô£¬Ö±½Ó¾­·Ñ£º52ÍòÔª£¬±¾ÈËÅÅÃû£º1¡£¢Ú ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄêÏîÄ¿£¬¸ß·Ö±æÈÛ½âÇúÏß·ÖÎö¼¼ÊõÓÃÓÚ°©×éÖ¯ÈںϻùÒò¿ìËÙ¼ì²âµÄÑо¿£¬ÏîÄ¿Åú×¼ºÅ£º**£¬2016Äê1ÔÂ-2018Äê12Ô£¬Ö±½Ó¾­·Ñ£º18ÍòÔª£¬±¾ÈËÅÅÃû£º2¡£
´ú±íÎÄÕ¢٠Lu Weipeng, Li Mei, Wang Hai, Liu Lina, Lu Shen. An epidermal growth factor receptor exon 19 mutation in a mucin-producing gastric cancer sample from a Chinese patient. Japanese Journal of Clinical Oncology 2016 (Accepted). ͨѶ×÷Õߣ¬IF£º2.016
¢Ú Wei Hong, Lu Weipeng, Li Mei, Zhang Qiuping, Lu Shen. Concomitance of P-gp/LRP Expression with EGFR Mutations in Exons 19 and 21 in Non-Small Cell Lung Cancers. Yonsei Medical Journal 2016, 57(1): 50-57. ͨѶ×÷Õߣ¬IF£º1.287
¢Û Lu Weipeng, Wei Hong, Li Mei, Wang Hai, Liu Lina, Zhang Qiuping, Liu Lisha, Lu Shen. Identification of KRAS and PIK3CA but not BRAF mutations in patients with gastric cancer. Molecular Medicine Reports 2015, 12(1): 1219-24. ͨѶ×÷Õߣ¬IF£º1.554
¢Ü Zhao Baoxia, Wang Jing, Song Bo, Wei Hong, Lv Weipeng, Tian Limin, Li Mei, Lv Shen. Establishment and biological characteristics of acquired gefitinib resistance in cell line NCI-H1975/gefinitib-resistant with epidermal growth factor receptor T790M mutation. Molecular Medicine Reports 2015, 11(4): 2767-2774. ͨѶ×÷Õߣ¬IF£º1.554
¢Ý Wang Jing, Wei Hong, Zhao Baoxia, Li Mei, Lv Weipeng, Lv Ling, Song Bo, Lv Shen. The reverse effect of X-ray irradiation on acquired gefitinib resistance in non-small cell lung cancer cell line NCI-H1975 in vitro, Journal of Molecular Histology 2014, 45(6): 641-652. ͨѶ×÷Õߣ¬IF£º1.815
¢Þ Li Mei, Wei Minghai, Jiang Zhenfu, Wei Hong, Lu Weipeng, Dou Wei, Lu Shen, BRAF Overexpression induces rampant glioma proliferation independent of phospho-EGFR expression, Advances in Clinical and Experimental Medicine 2014, 23(6): 893-899. ͨѶ×÷Õߣ¬IF£º1.095
¢ß Li Mei, Zhang Qiuping, Liu Lina, Lu Weipeng, Wei Hong, Li Rachel W, Lu Shen, Expression of the mismatch repair gene hMLH1 is enhanced in non-small cell lung cancer with EGFR mutations, PLoS One 2013, 8(10): e78500-e78500. ͨѶ×÷Õߣ¬IF£º3.534
¢à Liu Zhimin, Liu Lina, Li Mei, Wang Zhaohui, Feng Lu, Zhang Qiuping, Cheng Shihua, Lu Shen, Epidermal growth factor receptor mutation in gastric cancer, Pathology 2011, 43(3): 234-238. ͨѶ×÷Õߣ¬IF£º2.387
¢á Feng Lu, Li Mei, Zhang Qiuping, Piao Zhengai, Wang Zhaohui, Lv Shen, Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma, Oncology letters 2011, 2(1): 59-63. ͨѶ×÷Õߣ¬IF£º0.108
¢â Lv Shen, Lv Weipeng, Liu Lina, Li Mei, Li Xiaoyan, Over-expression of HER2 and mutation of PI3KCA and KRAS in Chinese gastric Carcinoma, Association for Molecular Pathology (AMP) Annual Meeting, 2013.11.14-2013.11.16. µÚÒ»×÷Õߣ¨»áÒéÂÛÎÄ£©£¬IF£º3.576